Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Presynaptic Imaging in Major Depressive Episodes After COVID-19

NCT06086366 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.

NCT NCT06086366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06086366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Presynaptic Imaging in Major Depressive Episodes After COVID-19
Lead sponsor
Centre for Addiction and Mental Health
Phase
Observational
Overall status
Recruiting
Start date
August 22, 2023
Completion date
September 10, 2028
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid, major depressive disorder, major depressive episode